Literature DB >> 11951150

Sexual dysfunction caused by reboxetine.

E M Haberfellner1.   

Abstract

The author reports on self-experienced, reboxetine-induced sexual dysfunction (prolonged orgasm of reduced intensity) and seminal emission after defecation. Both disorders were accompanied by pain and ceased within two days after discontinuation of the drug.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11951150     DOI： 10.1055/s-2002-25025

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN： 0176-3679            Impact factor:   5.788


  3 in total

1.  Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

Authors:  Teruhiko Higuchi; Mike Briley
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

2.  Erotic stimulus processing under amisulpride and reboxetine: a placebo-controlled fMRI study in healthy subjects.

Authors:  Heiko Graf; Maike Wiegers; Coraline D Metzger; Martin Walter; Georg Grön; Birgit Abler
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

3.  Spontaneous Ejaculation Induced with Atomoxetine.

Authors:  Ferhat Yaylacı; Begüm Şahbudak; Önder Küçük
Journal:  Psychopharmacol Bull       Date:  2020-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.